Akeso Beheer

Beheer criteriumcontroles 3/4

De CEO Akeso is Michelle Xia, benoemd in Mar2012, heeft een ambtstermijn van 12.67 jaar. De totale jaarlijkse vergoeding van { bedraagt CN¥ 6.52M, bestaande uit 67% salaris en 33% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 8.78% van de aandelen van het bedrijf, ter waarde HK$ 5.69B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2.3 jaar en 5 jaar.

Belangrijke informatie

Michelle Xia

Algemeen directeur

CN¥6.5m

Totale compensatie

Percentage CEO-salaris67.0%
Dienstverband CEO12.7yrs
Eigendom CEO8.8%
Management gemiddelde ambtstermijn2.3yrs
Gemiddelde ambtstermijn bestuur5yrs

Recente managementupdates

Akeso, Inc.'s (HKG:9926) CEO Compensation Is Looking A Bit Stretched At The Moment

Jun 24
Akeso, Inc.'s (HKG:9926) CEO Compensation Is Looking A Bit Stretched At The Moment

Recent updates

Optimistic Investors Push Akeso, Inc. (HKG:9926) Shares Up 27% But Growth Is Lacking

Sep 09
Optimistic Investors Push Akeso, Inc. (HKG:9926) Shares Up 27% But Growth Is Lacking

Akeso, Inc. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Aug 30
Akeso, Inc. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Akeso, Inc.'s (HKG:9926) CEO Compensation Is Looking A Bit Stretched At The Moment

Jun 24
Akeso, Inc.'s (HKG:9926) CEO Compensation Is Looking A Bit Stretched At The Moment

Little Excitement Around Akeso, Inc.'s (HKG:9926) Revenues As Shares Take 25% Pounding

Jun 19
Little Excitement Around Akeso, Inc.'s (HKG:9926) Revenues As Shares Take 25% Pounding

Are Investors Undervaluing Akeso, Inc. (HKG:9926) By 43%?

May 31
Are Investors Undervaluing Akeso, Inc. (HKG:9926) By 43%?

Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

Apr 24
Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

We Think Akeso's (HKG:9926) Robust Earnings Are Conservative

Mar 25
We Think Akeso's (HKG:9926) Robust Earnings Are Conservative

Results: Akeso, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Mar 20
Results: Akeso, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

Dec 28
Insufficient Growth At Akeso, Inc. (HKG:9926) Hampers Share Price

An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 34% Undervalued

Nov 16
An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 34% Undervalued

Is Akeso (HKG:9926) Using Too Much Debt?

Oct 02
Is Akeso (HKG:9926) Using Too Much Debt?

The Akeso, Inc. (HKG:9926) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

Aug 31
The Akeso, Inc. (HKG:9926) Half-Yearly Results Are Out And Analysts Have Published New Forecasts

Is Akeso, Inc. (HKG:9926) Trading At A 40% Discount?

Jun 26
Is Akeso, Inc. (HKG:9926) Trading At A 40% Discount?

There's Reason For Concern Over Akeso, Inc.'s (HKG:9926) Price

May 22
There's Reason For Concern Over Akeso, Inc.'s (HKG:9926) Price

Health Check: How Prudently Does Akeso (HKG:9926) Use Debt?

Apr 11
Health Check: How Prudently Does Akeso (HKG:9926) Use Debt?

Growth Investors: Industry Analysts Just Upgraded Their Akeso, Inc. (HKG:9926) Revenue Forecasts By 18%

Mar 21
Growth Investors: Industry Analysts Just Upgraded Their Akeso, Inc. (HKG:9926) Revenue Forecasts By 18%

An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 49% Undervalued

Mar 02
An Intrinsic Calculation For Akeso, Inc. (HKG:9926) Suggests It's 49% Undervalued

Akeso, Inc.'s (HKG:9926) Intrinsic Value Is Potentially 95% Above Its Share Price

Nov 01
Akeso, Inc.'s (HKG:9926) Intrinsic Value Is Potentially 95% Above Its Share Price

Analyse CEO-vergoeding

Hoe is Michelle Xia's beloning veranderd ten opzichte van Akeso's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-CN¥735m

Mar 31 2024n/an/a

CN¥646m

Dec 31 2023CN¥7mCN¥4m

CN¥2b

Sep 30 2023n/an/a

CN¥2b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥409m

Dec 31 2022CN¥5mCN¥4m

-CN¥1b

Sep 30 2022n/an/a

-CN¥1b

Jun 30 2022n/an/a

-CN¥1b

Mar 31 2022n/an/a

-CN¥1b

Dec 31 2021CN¥7mCN¥4m

-CN¥1b

Sep 30 2021n/an/a

-CN¥1b

Jun 30 2021n/an/a

-CN¥929m

Mar 31 2021n/an/a

-CN¥983m

Dec 31 2020CN¥7mCN¥3m

-CN¥1b

Sep 30 2020n/an/a

-CN¥870m

Jun 30 2020n/an/a

-CN¥703m

Mar 31 2020n/an/a

-CN¥492m

Dec 31 2019CN¥2mCN¥1m

-CN¥282m

Compensatie versus markt: De totale vergoeding ($USD 900.42K ) Michelle } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 887.73K ).

Compensatie versus inkomsten: De vergoeding van Michelle is gestegen terwijl het bedrijf verliesgevend is.


CEO

Michelle Xia (57 yo)

12.7yrs

Tenure

CN¥6,524,000

Compensatie

Dr. Yu Xia, Ph D., also known as Michelle, is CEO & President of Akeso Biopharma, Inc. Dr. Xia is Founder of Akeso, Inc. Dr. Xia is CEO, President & Chairwoman of Akeso, Inc. from March 19, 2012. She has b...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Yu Xia
Founder12.7yrsCN¥6.52m8.78%
HK$ 5.7b
Baiyong Li
Co-Founder12.7yrsCN¥5.02m5.98%
HK$ 3.9b
Zhongmin Wang
Co-Founderno dataCN¥3.60m5.04%
HK$ 3.3b
Yu Xia
Senior Vice Presidentless than a yearCN¥33.65mgeen gegevens
Peng Zhang
Co-Founderno datageen gegevensgeen gegevens
Bing Wang
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Xinfeng Zhang
Senior Vice President4.3yrsgeen gegevensgeen gegevens
Mingxiu Hu
Senior Vice President2.8yrsgeen gegevensgeen gegevens
Charlie Zhang
Senior Vice President1.8yrsgeen gegevensgeen gegevens
Jing Min
Senior Vice President1.8yrsgeen gegevensgeen gegevens
Wai Yan Leung
Company Secretary2.3yrsgeen gegevensgeen gegevens

2.3yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 9926 wordt beschouwd als ervaren (gemiddelde ambtstermijn 2.3 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Yu Xia
Founder12.7yrsCN¥6.52m8.78%
HK$ 5.7b
Baiyong Li
Co-Founder5yrsCN¥5.02m5.98%
HK$ 3.9b
Zhongmin Wang
Co-Founder5yrsCN¥3.60m5.04%
HK$ 3.3b
Peng Zhang
Co-Founderless than a yeargeen gegevensgeen gegevens
Bo Tan
Independent Non-Executive Directorno dataCN¥317.00kgeen gegevens
Ronggang Xie
Non-Executive Director4.3yrsgeen gegevensgeen gegevens
Yan Xu
Independent Non-Executive Directorno dataCN¥319.00kgeen gegevens
Junwen Zeng
Independent Non-Executive Directorno dataCN¥317.00kgeen gegevens

5.0yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 9926 wordt beschouwd als ervaren (gemiddelde ambtstermijn 5 jaar).